All Updates

All Updates

icon
Filter
Funding
RareCyte raises USD 20 million in venture funding to expand spatial biology platform
Precision Medicine
Jun 27, 2024
Last week:
Product updates
Eve Air Mobility unveils unmanned eVTOL prototype
Passenger eVTOL Aircraft
Yesterday
Product updates
Lilium advances POWER-ON, providing solutions with leading digital innovators
Passenger eVTOL Aircraft
Yesterday
Industry news
New South Korean space agency provides rundown of plans
Space Travel and Exploration Tech
Jul 20, 2024
Regulation/policy
Airwallex secures license to expand retail investment offerings in Australia
FinTech Infrastructure
Jul 19, 2024
Partnerships
EHang collaborates with KC Smart Mobility to expand EH216-S sales and operations in China
Passenger eVTOL Aircraft
Jul 19, 2024
Industry news
China launches Gaofen-11 high-resolution intelligence satellite
Satellite Management
Jul 19, 2024
Industry news
France funds miniature satellite capture and inspection mission
Satellite Management
Jul 19, 2024
Funding
Partnerships
MyFloraDNA launches crowdfunding campaign to address peanut allergies using CRISPR technology
Crop Biotech
Jul 19, 2024
Partnerships
Ecobloom Technologies partners with Harvest Today to enhance global farming practices
Smart Farming
Jul 19, 2024
Funding
Hyzon Motors announces registered direct offering to raise USD 4.5 million
Truck Industry Tech
Jul 19, 2024
Precision Medicine

Precision Medicine

Jun 27, 2024

RareCyte raises USD 20 million in venture funding to expand spatial biology platform

Funding

  • RareCyte has raised USD 20 million in a venture funding round that included Forest Road, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, 5AM Ventures, and Agilent Technologies.

  • The company plans to use the funds to expand RareCyte's primary platform, Orion Spatial Biology, which includes commercializing new multiplex assays, reagent products, and software applications. The funds will also enhance RareCyte's Precision Biology Services, such as spatial biology and liquid biopsy assays, and aid in global commercial expansion outside the US. 

  • Analyst Quicktake: The Orion spatial biology analysis platform was first made available for clinical research in 2020. In September 2021 , RareCyte raised USD 24 million in a Series G funding round to fast-track the platform's commercialization and applications. Arboretum Ventures led the round, which was jointly funded by new and existing investors.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.